FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, namely to delivery of anti-cancer agents to mammal cells. Invention enables to obtain conjugate of Angiopep-2 polypeptide aprotinin with three taxol molecules, which can be used in therapy of patients suffering from cerebral cancer.
EFFECT: obtained conjugate can effectively overcome blood-brain barrier in mammal and deliver drug to brain cells.
3 cl, 9 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYPEPTIDE CAPABLE OF OVERCOMING HEMATOENCEPHALIC BARRIER, AND CONJUGATE THEREOF | 2005 |
|
RU2408605C2 |
| INTENSIFICATION OF ACTION OF ANTICANCER AGENTS | 2006 |
|
RU2422143C2 |
| ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY | 2009 |
|
RU2531591C2 |
| COMPOSITION BASED ON HYDROPHOBIC AGENTS AND METHOD FOR PREPARING IT (VERSIONS) | 2009 |
|
RU2518240C2 |
| BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | 2014 |
|
RU2693438C2 |
| BLOOD BRAIN BARRIER SHUTTLE | 2013 |
|
RU2663120C2 |
| BIOLOGICALLY ACTIVE DERIVATIVES OF PEPTIDE VAPEEHPTLLTEAPLNPK | 2005 |
|
RU2377249C2 |
| SHUTTLE FOR BLOOD-BRAIN BARRIER | 2013 |
|
RU2711552C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| METHODS AND COMPOSITIONS FOR IMPROVED DELIVERY OF MACROMOLECULES | 2009 |
|
RU2522245C2 |
